CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN PREVENTION OF CISPLATIN-INDUCED EMESIS

被引：1
|
作者：
EGROS, F
DUFOUR, A
CAZOR, JL
机构：
来源：
LANCET | 1992年 / 340卷 / 8819期
关键词：
D O I：
10.1016/0140-6736(92)92161-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 619
页数：1
相关论文
共 50 条
  • [1] A RANDOMIZED TRIAL OF HIGH-DOSE BOLUS METOCLOPRAMIDE VERSUS LOW-DOSE CONTINUOUS INFUSION METOCLOPRAMIDE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
    DANA, BW
    MCDERMOTT, M
    EVERTS, E
    ABDULHAY, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 253 - 256
  • [2] METOCLOPRAMIDE KINETICS AT HIGH-DOSE INFUSION RATES FOR PREVENTION OF CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    BRIEMANN, L
    HELLSTERN, A
    HESS, H
    MITROU, P
    HODGSON, M
    ACHTERT, G
    BROCKMANN, P
    HAUSLEITER, HJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (01) : 43 - 47
  • [3] CONTINUOUS-INFUSION VERSUS INTERMITTENT SHORT INFUSION OF METOCLOPRAMIDE FOR CISPLATIN-INDUCED ACUTE EMESIS
    SAITO, H
    SHIMOKATA, K
    YAMORI, S
    KAJITA, M
    NIIMI, T
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (05): : 422 - 426
  • [4] OPTIMIZING ANTIEMESIS IN CANCER-CHEMOTHERAPY - EFFICACY OF CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN EMESIS INDUCED BY CISPLATIN
    WARRINGTON, PS
    ALLAN, SG
    CORNBLEET, MA
    MACPHERSON, JS
    SMYTH, JF
    LEONARD, RCF
    BRITISH MEDICAL JOURNAL, 1986, 293 (6558): : 1334 - 1337
  • [5] HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS
    AASEBO, U
    SLORDAL, L
    PRYTZ, PS
    AARBAKKE, J
    PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05): : 337 - 339
  • [6] CONTINUOUS IV INFUSION VERSUS MULTIPLE BOLUS DOSES OF METOCLOPRAMIDE FOR PREVENTION OF CISPLATIN-INDUCED EMESIS
    AGOSTINUCCI, WA
    GANNON, RH
    GOLUB, GR
    MARTIN, RS
    SCHAUER, PK
    DINONNO, EB
    CLINICAL PHARMACY, 1988, 7 (06): : 454 - 457
  • [7] HIGH-DOSE DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE VERSUS HIGH-DOSE DEXAMETHASONE AND SULPIRIDE IN THE MANAGEMENT OF CISPLATIN-INDUCED EMESIS
    ROSENBLATT, E
    LEV, LM
    ROBINSON, E
    ONCOLOGY, 1988, 45 (04) : 297 - 299
  • [8] CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE - COMPARISON OF PHARMACOKINETICALLY ADJUSTED AND STANDARD DOSES FOR THE CONTROL OF CISPLATIN-INDUCED ACUTE EMESIS
    BRECHOT, JM
    DUPEYRON, JP
    DELATTRE, C
    CHASTANG, C
    LAABAN, JP
    ROCHEMAURE, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 283 - 286
  • [9] USE OF HIGH-DOSE METHYLPREDNISOLONE IN COMBINATION WITH METOCLOPRAMIDE TO PREVENT CISPLATIN-INDUCED EMESIS
    WENDLING, JL
    CVITKOVIC, E
    CALS, L
    RECONDO, G
    BOUSSEN, H
    SEMAINE DES HOPITAUX, 1988, 64 (19): : 1315 - 1317
  • [10] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
12345